《新股》廣州農業機器人公司極飛科技遞表申請赴港IPO
廣州農業機器人公司極飛科技向港交所遞交招股說明書,申請赴港IPO。IPO募集所得資金淨額將主要用於研發農業機器人產品,以涵蓋農作物管理各個方面,從而提升市場份額和知名度,並將用於建立新總部及作營運資金之用。
說明書提到,自成立以來,極飛科技將研發目標聚焦在農業生產的管理環節,將新能源、智能化及機器人技術相融合,開發全新的農業機器人產品。於2022年至2024年,極飛科技營業收入分別為6.05億元人民幣(下同)、6.14億元和10.66億元;毛利率分別為17.9%、18.9%和31.9%。(ta/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.